A detailed history of Valeo Financial Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 2,120 shares of ILMN stock, worth $288,786. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,120
Holding current value
$288,786
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$105.28 - $135.9 $223,193 - $288,108
2,120 New
2,120 $276,000
Q1 2024

Apr 19, 2024

BUY
$127.73 - $147.2 $226,593 - $261,132
1,774 New
1,774 $243,000
Q2 2021

Jul 22, 2021

SELL
$372.84 - $481.5 $83,143 - $107,374
-223 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$361.28 - $504.76 $2,167 - $3,028
6 Added 2.76%
223 $86,000
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $5,854 - $7,419
20 Added 10.15%
217 $80,000
Q3 2020

Oct 28, 2020

BUY
$268.51 - $400.74 $26,851 - $40,074
100 Added 103.09%
197 $61,000
Q2 2020

Jul 20, 2020

BUY
$256.46 - $373.01 $8,206 - $11,936
32 Added 49.23%
97 $36,000
Q1 2020

Apr 13, 2020

SELL
$209.2 - $335.53 $3,556 - $5,704
-17 Reduced 20.73%
65 $19,000
Q4 2019

Jan 24, 2020

SELL
$288.29 - $335.49 $5,477 - $6,374
-19 Reduced 18.81%
82 $27,000
Q3 2019

Oct 15, 2019

SELL
$266.84 - $378.23 $4,536 - $6,429
-17 Reduced 14.41%
101 $31,000
Q2 2019

Jul 10, 2019

BUY
$300.59 - $368.15 $901 - $1,104
3 Added 2.61%
118 $43,000
Q1 2019

Apr 12, 2019

BUY
$272.57 - $321.18 $17,717 - $20,876
65 Added 130.0%
115 $36,000
Q3 2018

Nov 01, 2018

BUY
$279.04 - $367.06 $1,395 - $1,835
5 Added 11.11%
50 $16,000
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $7,753 - $9,626
45
45 $9,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.